Fri, July 29, 2022

Joshua Spector Maintained (CC) at Hold with Increased Target to $37 on, Jul 29th, 2022

Joshua Spector of UBS, Maintained "The Chemours Company" (CC) at Hold with Increased Target from $35 to $37 on, Jul 29th, 2022.

Joshua has made no other calls on CC in the last 4 months.



There are 4 other peers that have a rating on CC. Out of the 4 peers that are also analyzing CC, 3 agree with Joshua's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew DeYoe of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $44 on, Tuesday, June 14th, 2022
  • Michael Leithead of "Barclays" Maintained at Hold with Increased Target to $46 on, Monday, May 9th, 2022
  • Vincent Andrews of "Morgan Stanley" Maintained at Hold with Increased Target to $41 on, Monday, May 9th, 2022


This is the rating of the analyst that currently disagrees with Joshua


  • Arun Viswanathan of "RBC Capital" Maintained at Buy with Increased Target to $48 on, Wednesday, May 4th, 2022